Self-Assembled Nanoparticles from the Amphiphilic Prodrug of Resiquimod for Improved Cancer Immunotherapy
ACS Applied Materials & Interfaces · 2024
DOI: 10.1021/acsami.4c01563 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2024. Verfasst von Jia-Xian Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, South China University of Technology, Guangzhou 510006, China. Hauptthemen laut MEDLINE: Prodrugs, Immunotherapy, Imidazoles, Nanoparticles. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: Basic and Applied Basic Research Foundation of Guangdong Province, China Postdoctoral Science Foundation, Guangzhou Municipal Science and Technology Program key projects.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medicine, South China University of Technology, Guangzhou 510006, China.
- School of Biomedical Sciences and Engineering, Guangzhou International Campus, South China University of Technology, Guangzhou 511442, China.
- School of Biology and Biological Engineering, South China University of Technology, Guangzhou 510006, China.
- National Engineering Research Center for Tissue Restoration and Reconstruction, South China University of Technology, Guangzhou 510006, China.
- Innovation Centre of Ministry of Education for Development and Diseases, School of Medicine, South China University of Technology, Guangzhou 510006, China.
ORCID-Profile: Ling Wang, Jin-Zhi Du
Förderung
- Basic and Applied Basic Research Foundation of Guangdong Province
- China Postdoctoral Science Foundation
- Guangzhou Municipal Science and Technology Program key projects
- Fundamental Research Funds for the Central Universities
- National Natural Science Foundation of China
Zitieren
APA
Li, J. X., Shu, N., Zhang, Y. J., Tong, Q. S., Wang, L., Zhang, J. Y., & Du, J. Z. (2024). Self-Assembled Nanoparticles from the Amphiphilic Prodrug of Resiquimod for Improved Cancer Immunotherapy. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.4c01563
Vancouver
Li JX, Shu N, Zhang YJ, Tong QS, Wang L, Zhang JY, et al. Self-Assembled Nanoparticles from the Amphiphilic Prodrug of Resiquimod for Improved Cancer Immunotherapy. ACS Applied Materials & Interfaces. 2024. doi:10.1021/acsami.4c01563
BibTeX
@article{Li2024,
author = {Li, Jia-Xian and Shu, Na and Zhang, Yao-Jun and Tong, Qi-Song and Wang, Ling and Zhang, Jing-Yang and Du, Jin-Zhi},
title = {Self-Assembled Nanoparticles from the Amphiphilic Prodrug of Resiquimod for Improved Cancer Immunotherapy},
journal = {ACS Applied Materials & Interfaces},
year = {2024},
doi = {10.1021/acsami.4c01563}
}
EUVIMED